SIR,-We read with interest the report of Alam and colleagues implicating prostacyclin (PGI2) in the pathogenesis of haemolytic uraemic syndrome after acute shigellosis.' However, we were confused by the methodology that they used to establish the PGI2 concentrations in the plasma from their patients.
The authors state their intention to measure PGI2 by firstly incubating rabbit aortic rings with their patients' plasma, and then subsequently assaying 6-keto-PGF,,, in the incubation fluid, a method described by 
